Actemra 200mg, a drug known scientifically as tocilizumab, represents a potent therapeutical agent primarily utilized for the control of rheumatoid arthritis. This powerful agent acts by interfering with the activity of interleukin-6 (IL-6), a communication protein vital in the inflammatory process. Furthermore, Actemra has shown promise in the co